Home > Insider Trading > Filing (0000874716-23-000043)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
874716	Idexx Laboratories Inc	IDXX	In Vitro & In Vivo Diagnostic Substances (2835)	010393723

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1094176	Anne M Szostak	One Idexx Drive Westbrook ME 04092		Yes	No	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Disposition	2023-05-05	700	$473.59	6,000	No	4	S	Indirect	Trust of M. Anne Szostak
Common Stock	Disposition	2023-05-05	800	$475.27	5,200	No	4	S	Indirect	Trust of M. Anne Szostak
Common Stock	Disposition	2023-05-05	500	$476.12	4,700	No	4	S	Indirect	Trust of M. Anne Szostak

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	S	Indirect	Trust of M. Anne Szostak
No	4	S	Indirect	Trust of M. Anne Szostak
No	4	S	Indirect	Trust of M. Anne Szostak

Reported Non-Derivative Holdings

Sec. Name	Remaning Holdings	Nature of Ownership	Explanation
Common Stock	1,260	Direct

Footnotes

Represents the weighted average price of the shares sold ranging from a low of $473.17 to a high of $474.13 per share. The undersigned undertakes, upon request by the Commission staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares purchased at each separate price.
The reporting person is the settlor of the Trust of M. Anne Szostak ("Trust") and the trustee of the Trust, has power to direct the distribution of Trust assets, and has the power to revoke or amend the Trust. The reporting person has a pecuniary interest in the shares transferred to the Trust.
Represents the weighted average price of the shares sold ranging from a low of $474.67 to a high of $475.66 per share. The undersigned undertakes, upon request by the Commission staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares purchased at each separate price.
Represents the weighted average price of the shares sold ranging from a low of $475.84 to a high of $476.31 per share. The undersigned undertakes, upon request by the Commission staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares purchased at each separate price.